Lasa Supergenerics Ltd
NSE: LASA BSE: 540702
₹8.93
(0.22%)
Sat, 14 Feb 2026, 06:23 am
Market Cap436.88M
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KLasa Supergenerics Income Statement
| Particulars | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.99B | 2.44B | 1.69B | 1.67B | 2.02B | 1.37B | 1.30B | 1.04B | 1.42B |
| Gross profit | 411.05M | 297.11M | -24.02M | 263.39M | 423.04M | 119.58M | -111.52M | 121.03M | 178.53M |
| Operating expenses (excl. COGS) | -30.04M | -66.03M | -55.59M | -107.64M | -106.03M | -96.36M | -69.76M | -206.10M | -238.87M |
| Selling/general/admin expenses, total | -29.80M | -64.73M | -55.59M | -107.04M | -99.69M | -83.98M | -68.07M | -206.10M | -238.87M |
| Research & development | -1.70M | -2.15M | -1.64M | -3.38M | -3.74M | -2.02M | -1.02M | -1.32M | — |
| Selling/general/admin expenses, other | -28.10M | -62.58M | -53.94M | -103.66M | -95.95M | -81.96M | -67.05M | -206.10M | -238.87M |
| Other operating expenses, total | -242.00K | -1.29M | 0 | -601.00K | -6.35M | -12.38M | -1.69M | -683.00K | — |
| Operating income | 381.01M | 231.08M | -79.61M | 155.75M | 317.01M | 23.23M | -181.28M | -85.07M | -60.34M |
| Non-operating income, total | -359.58M | -78.75M | -81.42M | -108.38M | -22.09M | -84.62M | -241.37M | -106.06M | -133.49M |
| Interest expense, net of interest capitalized | -116.77M | -113.44M | -120.21M | -81.04M | -19.63M | -403.00K | -41.61M | -19.32M | -26.92M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 19.67M | 34.85M | 38.79M | -2.50M | -1.96M | -84.22M | -199.76M | -86.74M | -106.57M |
| Non-operating interest income | 21.74M | 34.14M | 37.99M | 2.31M | 490.00K | 837.00K | 274.00K | 0 | 0 |
| Miscellaneous non-operating expense | -2.08M | 717.00K | 805.00K | -4.81M | -2.45M | -85.05M | -200.04M | -86.74M | -106.57M |
| Unusual income/expense | -262.48M | -169.00K | 0 | -24.84M | -500.00K | 0 | 0 | 0 | 0 |
| Pretax income | 21.43M | 152.33M | -161.03M | 47.36M | 294.91M | -61.39M | -422.65M | -191.12M | -193.83M |
| Taxes | 2.20M | -28.93M | 40.72M | -11.08M | -67.14M | 8.08M | 36.44M | -26.18M | 46.26M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 23.62M | 123.40M | -120.31M | 36.28M | 227.78M | -53.31M | -386.21M | -217.31M | -147.57M |
| Net income | 23.62M | 123.40M | -120.31M | 36.28M | 227.78M | -53.31M | -386.21M | -217.31M | -147.57M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 23.62M | 123.40M | -120.31M | 36.28M | 227.78M | -53.31M | -386.21M | -217.31M | -147.57M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - |
| EBITDA | 457.89M | 412.75M | 113.47M | 329.13M | 475.25M | 168.34M | -47.09M | 21.66M | 62.66M |
| EBIT | 381.01M | 231.08M | -79.61M | 155.75M | 317.01M | 23.23M | -181.28M | -85.07M | -60.34M |
| Total operating expenses | -1.61B | -2.20B | -1.77B | -1.52B | -1.70B | -1.35B | -1.48B | -1.13B | -1.48B |
| Prepaid expenses | 555.00K | 1.51M | 862.00K | 200.48M | 103.00K | 24.96M | 45.83M | 33.33M | — |
| Deferred income, current | 39.59M | 67.82M | 20.72M | 9.34M | 355.00K | 1.83M | 1.13M | 226.00K | — |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 19.43M | 16.66M | — | — | 78.22M | 59.12M | 22.35M | 48.48M | 2.22M |
| Deferred income, non-current | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800